Odomzo (sonidegib) Disease Interactions
There are 2 disease interactions with Odomzo (sonidegib):
Hedgehog pathway inhibitors (Includes Odomzo) ↔ musculoskeletal disorders
Moderate Potential Hazard, Moderate plausibility. Applies to: History - Musculoskeletal Disorder
Musculoskeletal adverse reactions, which may be accompanied by serum creatine kinase elevations have been reported with the use of drugs that inhibit the hedgehog pathway. It is recommended to obtain serum creatine kinase levels and renal function tests prior to initiating therapy, periodically during treatment, and as clinically indicated. Care should be taken when prescribing these agents to patients presenting musculoskeletal pain or myalgia. Temporary dose interruption or discontinuation of therapy may be required based on the severity of musculoskeletal adverse reactions.
Sonidegib (Includes Odomzo) ↔ renal impairment
Moderate Potential Hazard, Moderate plausibility. Applies to: Renal Dysfunction
Mild (CrCl 60 to 89 mL/min) and moderate (CrCl 30 to 59 mL/min) renal impairment had no effect on sonidegib steady-state exposure. Caution is recommended when this agent is administered to patients with severe renal impairment as no data is available from the manufacturer.
Odomzo (sonidegib) drug interactions
There are 176 drug interactions with Odomzo (sonidegib)
Odomzo (sonidegib) alcohol/food interactions
There is 1 alcohol/food interaction with Odomzo (sonidegib)
More about Odomzo (sonidegib)
- Odomzo Side Effects
- During Pregnancy
- Dosage Information
- Drug Images
- Drug Interactions
- Pricing & Coupons
- En Español
- Drug class: hedgehog pathway inhibitors
Related treatment guides
Drug Interaction Classification
|Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit.|
|Moderately clinically significant. Usually avoid combinations; use it only under special circumstances.|
|Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan.|
|No information available.|
Do not stop taking any medications without consulting your healthcare provider.
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.